Iradimed's market cap is currently ―. The company's EPS TTM is $1.351; its P/E ratio is 31.29; and it has a dividend yield of 0.35%. Iradimed is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 16.50M	$ 16.13M	$ 15.48M	$ 14.86M	$ 13.41M
Gross Profit	$ 12.84M	$ 16.13M	$ 11.72M	$ 11.22M	$ 10.54M
EBIT	$ 6.41M	$ 5.30M	$ 4.35M	$ 4.25M	$ 4.13M
EBITDA	$ 6.60M	$ 5.49M	$ 4.53M	$ 3.68M	$ 4.57M
Net Income Common Stockholders	$ 5.07M	$ 4.18M	$ 3.41M	$ 3.67M	$ 3.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 46.75M	$ 45.82M	$ 42.78M	$ 57.96M	$ 55.59M
Total Assets	$ 87.41M	$ 81.43M	$ 75.62M	$ 85.51M	$ 79.54M
Total Debt	$ 2.15M	$ 2.25M	$ 2.35M	$ 2.21M	$ 2.28M
Net Debt	$ -44.60M	$ -43.58M	$ -40.43M	$ -55.76M	$ -53.32M
Total Liabilities	$ 12.84M	$ 12.43M	$ 11.28M	$ 85.51M	$ 9.77M
Stockholders Equity	$ 74.57M	$ 69.00M	$ 64.34M	$ 73.67M	$ 69.77M
Cash Flow	-
Free Cash Flow	$ 953.66K	$ 3.14M	$ -1.91M	$ 2.57M	$ 3.38M
Operating Cash Flow	$ 1.39M	$ 3.51M	$ 4.65M	$ 3.04M	$ 3.94M
Investing Cash Flow	$ -439.02K	$ -378.31K	$ -6.56M	$ -471.68K	$ -556.19K
Financing Cash Flow	$ -31.37K	$ -89.77K	$ -13.27M	$ -198.46K	$ 52.34K

Currency in USD

Iradimed Earnings and Revenue History

Income Statement >

Iradimed Debt to Assets

Balance Sheet >

Iradimed Cash Flow

Cash Flow >

Iradimed Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing